AN2 Therapeutics, Inc. (ANTX) vs Eledon Pharmaceuticals, Inc. (ELDN)
A side-by-side comparison of AN2 Therapeutics, Inc. and Eledon Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANTX
AN2 Therapeutics, Inc.
$5.07HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ELDN
Eledon Pharmaceuticals, Inc.
$2.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ANTX vs ELDN
growth of $100 · dividends reinvested · last 5yANTX -63.6% (-18.3%/yr)ELDN -34.0% (-8.0%/yr)ELDN compounded faster over this window
ANTX ELDN
ANTX vs ELDN: by the numbers
- •ELDN is the larger company ($189M vs $183M market cap).
Metrics side by side
Valuation
| Metric | ANTX | ELDN |
|---|---|---|
| P/B ratio | 2.41 | 5.73 |
Profitability
| Metric | ANTX | ELDN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -47.78% | -136.83% |
| ROIC | -51.01% | -74.02% |
Growth (annualized)
| Metric | ANTX | ELDN |
|---|---|---|
| Total return CAGR (5Y) | N/A | -15.17% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.